Regulatory Mechanisms of MicroRNAs in Lung Cancer Stem Cells

Overview

Journal Springerplus

Date 2016 Nov 1

PMID 27795904

Citations 8

Authors

Tao Fan

Wei Wang

Boyou Zhang

Yao Xu

Lei Chen

Shize Pan

Hao Hu

Qing Geng

Affiliations

Soon will be listed here.

Abstract

Increasing evidence suggests that cancer stem cells (CSCs) are a key occurrence in the process of many human cancers. Lung cancer is the most common aggressive malignancy and cause of cancer death worldwide. The research on lung cancer stem cells has been highlighted for many years. Lung CSCs seem to play a major role in lung cancer metastasis, drug resistance and tumour-self-renewal. MicroRNAs (miRNAs), a class of newly emerging small noncoding RNAs that act as post-transcriptional regulators of gene expression, have been demonstrated to serve as a vital player in fine-tuning a number of biological activities ranging from embryogenesis to programmed cell death as well as tumourigenesis. In recent years, several miRNAs have been highlighted to be specifically expressed in CSCs. The miRNA profile of CSCs is remarkably different from non-stem cancer cells. As such, many miRNAs have been shown to regulate self-renewal and differentiation properties of CSCs. In this review, we present the latest findings on miRNAs that regulate the tumour microenvironment of lung CSCs with the goal to prompt the development of novel therapeutic strategies for patients with lung cancer.

Citing Articles

An insight into the associations between microRNA expression and mitochondrial functions in cancer cell and cancer stem cell.

Tan W, Subha S, Mohtarrudin N, Cheah Y Mol Biol Rep. 2023; 50(6):5395-5405.

PMID: 37074612 DOI: 10.1007/s11033-023-08421-5.

Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities.

Jaksic Karisik M, Lazarevic M, Mitic D, Nikolic N, Milosevic Markovic M, Jelovac D Int J Mol Sci. 2023; 24(5).

PMID: 36902135 PMC: 10002556. DOI: 10.3390/ijms24054704.

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.

Konoshenko M, Lansukhay Y, Krasilnikov S, Laktionov P Int J Mol Sci. 2022; 23(14).

PMID: 35886942 PMC: 9321818. DOI: 10.3390/ijms23147594.

The Antiviral Drug Efavirenz in Breast Cancer Stem Cell Therapy.

Chiou P, Ohms S, Board P, Dahlstrom J, Rangasamy D, Casarotto M Cancers (Basel). 2021; 13(24).

PMID: 34944852 PMC: 8699628. DOI: 10.3390/cancers13246232.

Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses.

Liang C, Li Z, Gan T, Fang Y, Gan B, Chen W Respir Res. 2020; 21(1):60.

PMID: 32102656 PMC: 7045575. DOI: 10.1186/s12931-020-1274-9.

References

Dumortier O, Hinault C, Van Obberghen E . MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab. 2013; 18(3):312-24. DOI: 10.1016/j.cmet.2013.06.004. View

Balca-Silva J, Sousa Neves S, Goncalves A, Abrantes A, Casalta-Lopes J, Botelho M . Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines. Anticancer Res. 2012; 32(5):1603-9. View

Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A . A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129(7):1401-14. PMC: 2681231. DOI: 10.1016/j.cell.2007.04.040. View

Bandi N, Vassella E . miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer. 2011; 10:55. PMC: 3120797. DOI: 10.1186/1476-4598-10-55. View

Lee Y, Kim M, Han J, Yeom K, Lee S, Baek S . MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004; 23(20):4051-60. PMC: 524334. DOI: 10.1038/sj.emboj.7600385. View

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

Serpico D, Molino L, Di Cosimo S . microRNAs in breast cancer development and treatment. Cancer Treat Rev. 2013; 40(5):595-604. DOI: 10.1016/j.ctrv.2013.11.002. View

Johnson S, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A . RAS is regulated by the let-7 microRNA family. Cell. 2005; 120(5):635-47. DOI: 10.1016/j.cell.2005.01.014. View

Hua S, Xiaotao X, Renhua G, Yongmei Y, Lianke L, Wen G . Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells. Biomed Pharmacother. 2012; 66(2):89-97. DOI: 10.1016/j.biopha.2011.09.013. View

10.

Wiggins J, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D . Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 2010; 70(14):5923-30. PMC: 2913706. DOI: 10.1158/0008-5472.CAN-10-0655. View

11.

Hollis M, Nair K, Vyas A, Chaturvedi L, Gambhir S, Vyas D . MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity. World J Gastroenterol. 2015; 21(27):8284-92. PMC: 4507098. DOI: 10.3748/wjg.v21.i27.8284. View

12.

Kurisetty V, Lakshmanaswamy R, Damodaran C . Pathogenic and therapeutic role of miRNAs in breast cancer. Front Biosci (Landmark Ed). 2014; 19(1):1-11. DOI: 10.2741/4192. View

13.

Peng C, Cherng J, Chiou G, Chen Y, Chien C, Kao C . Delivery of Oct4 and SirT1 with cationic polyurethanes-short branch PEI to aged retinal pigment epithelium. Biomaterials. 2011; 32(34):9077-88. DOI: 10.1016/j.biomaterials.2011.08.008. View

14.

Zhu H, Shyh-Chang N, V Segre A, Shinoda G, Shah S, Einhorn W . The Lin28/let-7 axis regulates glucose metabolism. Cell. 2011; 147(1):81-94. PMC: 3353524. DOI: 10.1016/j.cell.2011.08.033. View

15.

Ho M, Ng A, Lam S, Hung J . Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007; 67(10):4827-33. DOI: 10.1158/0008-5472.CAN-06-3557. View

16.

Fabian M, Sonenberg N . The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol. 2012; 19(6):586-93. DOI: 10.1038/nsmb.2296. View

17.

Mayr C, Hemann M, Bartel D . Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 2007; 315(5818):1576-9. PMC: 2556962. DOI: 10.1126/science.1137999. View

18.

Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H . The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011; 17(2):211-5. PMC: 3076220. DOI: 10.1038/nm.2284. View

19.

Liu X, Sempere L, Ouyang H, Memoli V, Andrew A, Luo Y . MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest. 2010; 120(4):1298-309. PMC: 2846041. DOI: 10.1172/JCI39566. View

20.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View